Article
Towards cascading genetic risk in Alzheimer’s disease
2023-12-17
Abstract excerpt
Alzheimer’s disease typically progresses in stages, which have been defined by the presence of disease-specific biomarkers: Amyloid (A), Tau (T) and neurodegeneration (N). This progression of biomarkers has been condensed into the ATN framework, where each of the biomarkers can be either positive (+) or negative (-). Over the past decades genome wide association studies have implicated about 90 different loci invo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3b18c9a4-6fce-58ea-bae7-072292f962bc
- DOI
- 10.1101/2023.12.16.23300062
